Viking Therapeutics (VKTX) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Viking Therapeutics (VKTX) over the last 7 years, with Q4 2025 value amounting to -$224000.0.
- Viking Therapeutics' Other Gross PP&E Adjustments rose 8530.18% to -$224000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$224000.0, marking a year-over-year increase of 8530.18%. This contributed to the annual value of -$224000.0 for FY2025, which is 8530.18% up from last year.
- Latest data reveals that Viking Therapeutics reported Other Gross PP&E Adjustments of -$224000.0 as of Q4 2025, which was up 8530.18% from -$1.1 million recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Other Gross PP&E Adjustments registered a high of -$188000.0 during Q3 2021, and its lowest value of -$1.9 million during Q2 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$1.5 million (2023), whereas its average is -$1.2 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 88776.6% in 2022, then soared by 8530.18% in 2025.
- Viking Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$383000.0 in 2021, then crashed by 366.32% to -$1.8 million in 2022, then increased by 15.73% to -$1.5 million in 2023, then fell by 1.26% to -$1.5 million in 2024, then surged by 85.3% to -$224000.0 in 2025.
- Its Other Gross PP&E Adjustments stands at -$224000.0 for Q4 2025, versus -$1.1 million for Q3 2025 and -$1.2 million for Q2 2025.